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ABSTRACT: Polyethylene glycol-functionalized nanographene oxide
(PEGylated n-GO) was synthesized from alkyne-modiﬁed n-GO, using
solvent-free click-mechanochemistry, i.e., copper(I)-catalyzed azide−alkyne
cycloaddition (CuAAC). The modiﬁed n-GO was subsequently conjugated to
a mucin 1 receptor immunoglobulin G antibody (anti-MUC1 IgG) via thiol−
ene coupling reaction. n-GO derivatives were characterized with Fourier-
transformed infrared (FT-IR) spectroscopy, thermogravimetric analysis
(TGA), Bradford assay, sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE), and atomic force microscopy (AFM). Cell targeting
was conﬁrmed in vitro in MDA-MB-231 cells, either expressing or lacking
MUC1 receptors, using ﬂow cytometry, confocal laser scanning microscopy
(CLSM) and multiphoton (MP) ﬂuorescence microscopy. Biocompatibility
was assessed using the modiﬁed lactate dehydrongenase (mLDH) assay.
KEYWORDS: antibody, nanomedicine, drug delivery, toxicity, breast cancer
Graphene is a novel two-dimensional (2D) nanomaterialformed from a single layer of carbon atoms. It has
attracted the attention of scientists working in diﬀerent ﬁelds
since the ﬁrst observation of graphene by Boehm-Hofmann1
and the discovery of single layer isolation.2 Graphene oxide
(GO) is useful in biomedical applications because of its good
dispersibility in aqueous media and easy modiﬁcation of its
functional groups.3 GO constitutes a promising material in
ﬁelds such as photothermal anticancer therapy,4 drug delivery,5
and gene delivery.6 Selectivity in cancer cell targeting remains
an unmet need thus preparation of nanocarriers capable of
eﬃcient and selective targeting of cancer cells is highly
desirable.7 Achieving this aim using facile and eco-friendly
(solvent-free) chemical methods adds value to the whole
approach.
In this work, PEGylated GO was successfully synthesized, for
the ﬁrst time, using the solvent-free click-mechanochemistry
approach. Azide- and maleimide-terminated bifunctional PEG
polymer was synthesized and characterized using 1H NMR and
FT-IR spectroscopy (Figure S1). GO was synthesized using a
modiﬁed Kovtyukhova-Hummer’s method that we have
reported previously.8 The carboxylic groups available in GO
were coupled to propargyl alcohol using the Steglich
esteriﬁcation reaction,9 yielding n-GO-alkyne (Scheme 1).
FT-IR spectroscopy was used to conﬁrm that the alkyne
group was introduced on the GO. However, the alkyne signal at
3292 cm−1 was masked by the O−H band from GO. For this
reason deuterium conversion was used to assess the presence of
alkyne groups introduced on GO (Figure 1A) as the new C−D
band displays a stronger signal at 2565 cm−1 compared with the
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Scheme 1. Synthesis of the PEGylated Nano-graphene Oxide
Targeting MUC1 (n-GO-PEG-MUC1)
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initial C−H band. The terminal hydrogen was replaced by
deuterium following a mild and eﬃcient protocol described by
Bew et al.10 (Figure S2A). The FT-IR spectrum (Figure S2A,
top panel) showed the appearance of a peak at 2565 cm−1 due
to the vibration of the C−D bond, proving the conversion of
propargyl alcohol to 2H-propargyl alcohol. Figure S2A shows
the GO-alkyne spectrum with a new band appearing at 2565
cm−1, after deuteration that corresponds to the vibration of the
bond C−D. The O−H of GO may also be converted to O−D,
which overlaps with the C−D bond. To eliminate this
possibility, we subjected GO (lacking alkyne) to deuteration
reaction conditions. No band was detected at 2565 cm−1
(Figure S2B), suggesting that the previously observed peak at
2565 cm−1 was due to the deuterium conversion.
Thermogravimetric analysis (TGA) (Figure 1B) showed
typical TGA proﬁle of GO, which agreed with previously
published data. An initial decrease at 200 °C was associated
with the removal of carboxylic/alcohol/epoxy groups.11 A
second decrease at 700 °C was due to the decomposition of the
graphitic skeleton of GO. Esteriﬁcation reaction with propargyl
alcohol yielding n-GO-alkyne resulted in an increase in the
thermal stability at the highest temperatures.
Subsequently, the maleimide/azide heterofunctionalized
polyethylene glycol (maleimide-NH-PEG3.5KDa-N3) was intro-
duced on n-GO-alkyne using solvent-free click-mechanochem-
istry namely the copper(I)-catalyzed azide−alkyne cyclo-
addition (CuAAC). Click-mechanochemistry has been applied
widely on small organic molecules12 but has never been
employed to modify GO. The resulting n-GO-PEG showed an
increase in weight loss from 46 to 55%, at 600 °C, conﬁrming
PEG introduction to GO (which corresponds to a PEG content
of 31 μmol per gram n-GO). The presence of PEG was
conﬁrmed by FT-IR spectroscopy (Figure 1C); the peak of C−
H stretching vibration was clearly observed at 2872 cm−1.
Functionalization of n-GO-alkyne with PEG polymer enhanced
the aqueous dispersibility of the system. The ﬁnal concentration
of the prepared n-GO-alkyne and n-GO-PEG was 0.3 and 0.75
mg/mL, respectively.
Anti-MUC1 IgG antibody was conjugated to the maleimide
addends using a thiol−ene coupling reaction, yielding n-GO-
PEG-MUC1. An increase in the weight loss from 55 to 71%,
was observed due to the antibody introduction to n-GO,
corresponding to 160.5 μg antibody per gram n-GO. Anti-
MUC1 IgG loading was also quantiﬁed using Bradford protein
assay (Figure S4). This assay is based on the change of the
absorbance of the Coomassie Blue dye when binding to
proteins.13 The increase in the absorption peak observed at 545
nm corresponded to 165.2 μg antibody per gram n-GO, which
correlates well with the amount calculated from TGA. Covalent
conjugation to anti-MUC1 IgG further enhanced the aqueous
dispersibility so that the ﬁnal concentration achieved for n-GO-
PEG-MUC1 was 1.05 mg/mL.
The structural properties of the n-GO conjugates were
studied using Raman spectroscopy (Figure S3A). Typical D
(1317 cm−1) and G (1610 cm−1) bands were observed,
corroborating that the graphitic structure of the layers was
preserved after mechanochemistry and subsequent IgG
functionalization. ID/IG peak height ratio for n-GO was 1.52
± 0.06 (n = 3, n corresponds to the number of Raman spectra
recorded), which is similar to n-GO-alkyne (ID/IG ratio = 1.59
± 0.03, n = 3) and n-GO-PEG (ID/IG ratio = 1.52 ± 0.04, n =
3) derivatives. This fact suggests that the structural properties
of the n-GO are maintained after the milling process, which
agrees with our preliminary n-GO-mechanochemistry studies.8
AFM measurements using the tapping mode (in air) were
performed in order to study the morphological properties. A
maximum/medium size of 2.15 μm2/62 nm2 was found for n-
GO, after 4 h bath sonication (n = 621).14 The height images of
n-GO-PEG and n-GO-PEG-MUC1 are shown in Figure S3B.
SDS-PAGE electrophoresis under denaturing/reducing
(protein separation based on mass diﬀerences) and native/
nonreducing (protein separation based on mass-charge ratio)
conditions was performed to analyze the interactions between
GO and the anti-MUC1 IgG antibody (Figure 1D). No bands
were observed for n-GO-PEG-MUC1 under nonreducing
conditions. The typical heavy and light chains were, as
expected, observed when carrying out the electrophoresis
under denaturing/reducing conditions. The results conﬁrmed
the stable conjugation of the antibody and n-GO-PEG. To
further conﬁrm the covalent conjugation between n-GO-PEG-
maleimide and the thiolated antibody (through thiol-maleimide
coupling), a mixing control study was performed using n-GO-
PEG-NH2 (lacking the maleimide group) and the thiolated
anti-MUC1 IgG. The result was analyzed using SDS-PAGE
under reducing condition (Figure S5). Signals for both the
heavy and light chains were seen only in the mixing control
(Figure S5, lane 2). In the conjugate n-GO-PEG-MUC1
(Figure S5, lane 3), only a faint signal for the light chain can be
seen, as the heavy chains were immobilized on the PEG
covalently.
The toxicity of the GO samples on breast cancer cell lines
MDA-MB-231-ME (MUC1+) and MDA-MB-231 (MUC1−)
was evaluated using the modiﬁed LDH assay (Figure S6).
Dimethyl sulfoxide (DMSO) (10% v/v) was used as a positive
toxic control. No signiﬁcant toxicity (<15% cell death) was
observed on cells incubated with n-GO-PEG and n-GO-PEG-
MUC1 at 10 μg/mL for 24 or 72 h, whereas higher
concentrations, i.e., 50 and 100 μg/mL, showed signiﬁcant
dose- and time-dependent toxicity (Figure S6). MUC1+ cells
were found to be more sensitive to targeted and nontargeted n-
GO than MUC1− cells. Moreover, n-GO-PEG-MUC1
Figure 1. Characterization of n-GO derivatives. (A) FT-IR measure-
ments of n-GO-alkyne before and after deuteration; (B) TGA graphs;
(C) FT-IR measurements of n-GO-alkyne before and after click
reaction. (D) SDS-PAGE gel electrophoresis under nonreducing
(right) and reducing (left) conditions of anti-MUC1 IgG (1) and n-
GO-PEG-MUC1 (2).
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exhibited a higher toxicity with MUC1+ cells (for the three
tested concentrations) when compared that with n-GO-PEG.
This eﬀect was more pronounced and statistically signiﬁcant at
72 h (p < 0.01 for 10 μg/mL, p < 0.001 for 50 and 100 μg/
mL).
The n-GO-PEG-MUC1 sample was further tested in the two
MDA-MB-231 breast cancer cell lines in order to conﬁrm the
intracellular delivery and the possible targeting eﬀect. Cells
were imaged using confocal laser scanning microscopy (CLSM)
and MP ﬂuorescence microscopy in order to detect the anti-
MUC1 IgG antibody and GO, respectively (Figure 2). The
multiphoton emission properties of GO have been recently
described;15 these studies demonstrated the broad emission
spectra of GO in the visible range, when excited using a
femtosecond laser. We have relied on these optical properties
for the detection of GO in cells. MUC1+ cells were incubated
with anti-MUC1 IgG, n-GO-PEG or n-GO-PEG-MUC1, at
concentrations equivalent to 2.5 μg/mL anti-MUC1 IgG for 3
h. This was equivalent to 10 μg/mL n-GOs, a concentration
that has proven to be nontoxic to cells under these conditions.
Cells were then ﬁxed, permeabilized and immunostained with
cyanine dye (Cy3)-labeled antihuman IgG, to track anti-MUC1
antibody. 4′-6-Diamidino-2-phenylindole (DAPI) was used to
visualize the nucleus (CLSM). Direct imaging of GO was
carried out using MP (green channel). The free antibody was
internalized in cells within 3 h of incubation. Stronger green
signals were detected in cells incubated with n-GO-PEG-
MUC1 than n-GO-PEG (Figure 2), suggesting higher
speciﬁcity of the former. CLSM conﬁrmed the presence of
anti-MUC1 IgG within the cells (red channel), red signals
corresponding with anti-MUC1 IgG colocalized with the green
signals of n-GO-PEG-MUC1, corroborating that anti-MUC1
IgG remained conjugated to n-GO-PEG after cellular internal-
ization. As expected, no red signals were observed for n-GO-
PEG (lacking the antibody). Images showing uptake in
MUC1− cells are shown in Figure S7. No uptake of anti-
MUC1 IgG (red channel) was observed in this instance
because of the absence of MUC1 receptors. The same cells
showed reduced uptake of n-GO-PEG-MUC1 than in MUC1+
cells adding further conﬁrmation of the targeting eﬀect of n-
GO-PEG-MUC1.
The uptake of n-GO-PEG-MUC1 in MUC1+ cells was also
assessed by ﬂow cytometry and the extent of uptake was
expressed as mean ﬂuorescence intensity (MFI) (Figure 3).
Cells were treated for 1, 3, and 24 h with anti-MUC1 IgG or n-
GO-PEG-MUC1 at concentrations equivalent to 2.5 μg/mL
anti-MUC1 IgG. n-GO-PEG was used as a control. At 1 h,
comparable results were obtained for both anti-MUC1 IgG and
n-GO-PEG-MUC1 with uptake only being observed in
MUC1+ cells. At 3 h, an increase in MFI was found in
MUC1− cells treated with n-GO-PEG-MUC1. This increase in
MFI, however, was signiﬁcantly lower than that observed in
MUC1+ cells. At 24 h, MUC1+ cells treated with n-GO-PEG-
MUC1 showed signiﬁcantly higher MFI values compared to all
treatment groups (Figure 3A), agreeing with CLSM and MP
results.
In summary, PEGylation of GO using click-mechanochem-
istry in the absence of solvents is demonstrated successfully for
the ﬁrst time. Targeting breast cancer cells in vitro is
accomplished through the introduction of an anti-MUC1
IgG. Selectivity to MUC1+ cells, at nontoxic concentrations,
was conﬁrmed using a variety of techniques including ﬂow
cytometry, CLSM, and MP imaging. The attractive chemical
Figure 2. Confocal laser scanning microscopy (CLSM) and
multiphoton (MP) ﬂuorescence microscopic images of MUC1+ cells
incubated with anti-MUC1 IgG, n-GO-PEG or n-GO-PEG-MUC1.
MUC1+ cells were incubated with individual treatments for 3 h then
stained with Cy3 labeled antihuman IgG (H+L) (red) and DAPI
(nuclei, blue) and imaged with CLSM (anti-MUC1 IgG, red) or MP
microscopy (GO, green). Objective used was 40×/1.25 NA. Scale bars
= 15 μm.
Figure 3. Intracellular uptake of n-GO-PEG-MUC1 in MUC1+ and
MUC1- human breast cancer cells in vitro. (A) Flow cytometric
proﬁles of MUC1+ and MUC1- cell lines treated with antiMUC1-IgG
or GO-PEG-MUC1 for 1 h, 3 or 24 h. Cellular uptake was assessed by
analyzing the shift in mean ﬂuorescence intensity (MFI). The
percentage of positive cells for MUC1− and MUC1+ cells are
shown in (B) and (C). Signals were collected using FL2 detector.
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approach used for functionalizing nGO combined with the
ability to selectively targeticancer cells in vitro are prerequisite
for further in vivo evaluation.
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